Investors

Share price

{{priceData.date}} {{priceData.time}}

{{priceData.currentPrice}} {{priceData.currency}}
Go to stock watch {{priceData.change}} {{priceData.currency}}

Quick links

Financial results Stock information Press releases and company announcements R&D pipeline Upcoming events

Novo Nordisk Annual Report

Cover page of the Novo Nordisk Annual Report 2023

Annual Report 2023

Latest news

{{'2025-01-17T12:11:58Z' | dateFormatFilter}}

Novo Nordisk A/S: Semaglutide 7.2 mg s.c. achieved 20.7% weight loss in the STEP UP obesity trial, and 18.7% regardless of treatment adherence

Read more

{{'2025-01-08T11:30:49Z' | dateFormatFilter}}

Valo Health and Novo Nordisk expand collaboration to discover and develop novel treatments for cardiometabolic diseases

Read more

{{'2024-12-20T10:41:55Z' | dateFormatFilter}}

Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight in the REDEFINE 1 trial

Read more

News archive

Career Opportunities

Dear colleague

Please click here to go directly to our internal career site to view all our current job openings.

Here are our current job openings. If there is not a job you are looking for, you are welcome to create a job agent or a candidate profile.